Supply chain: price cuts moderating but damage done

On 1 April a number of large volume drugs managed to avoid a sizable price cut, however the pharmaceutical supply chain has already suffered serious damage says Bruce Annabel. The principle reason for the reduced level of medicines experiencing price cuts was that certain drugs were excluded this time thanks to Government raising the WADP